|
Name |
Pestacin
|
Molecular Formula | C15H14O4 | |
IUPAC Name* |
2-(7-hydroxy-5-methyl-1,3-dihydro-2-benzofuran-1-yl)benzene-1,3-diol
|
|
SMILES |
CC1=CC2=C(C(OC2)C3=C(C=CC=C3O)O)C(=C1)O
|
|
InChI |
InChI=1S/C15H14O4/c1-8-5-9-7-19-15(13(9)12(18)6-8)14-10(16)3-2-4-11(14)17/h2-6,15-18H,7H2,1H3
|
|
InChIKey |
KXVCRSXYCVASDF-UHFFFAOYSA-N
|
|
Synonyms |
Pestacin; SCHEMBL14566967
|
|
CAS | NA | |
PubChem CID | 9965029 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 258.27 | ALogp: | 2.1 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 19 | QED Weighted: | 0.732 |
Caco-2 Permeability: | -4.749 | MDCK Permeability: | 0.00000659 |
Pgp-inhibitor: | 0.015 | Pgp-substrate: | 0.018 |
Human Intestinal Absorption (HIA): | 0.025 | 20% Bioavailability (F20%): | 0.86 |
30% Bioavailability (F30%): | 0.989 |
Blood-Brain-Barrier Penetration (BBB): | 0.037 | Plasma Protein Binding (PPB): | 94.64% |
Volume Distribution (VD): | 0.635 | Fu: | 3.48% |
CYP1A2-inhibitor: | 0.095 | CYP1A2-substrate: | 0.396 |
CYP2C19-inhibitor: | 0.125 | CYP2C19-substrate: | 0.512 |
CYP2C9-inhibitor: | 0.53 | CYP2C9-substrate: | 0.763 |
CYP2D6-inhibitor: | 0.692 | CYP2D6-substrate: | 0.478 |
CYP3A4-inhibitor: | 0.144 | CYP3A4-substrate: | 0.486 |
Clearance (CL): | 6.611 | Half-life (T1/2): | 0.737 |
hERG Blockers: | 0.045 | Human Hepatotoxicity (H-HT): | 0.107 |
Drug-inuced Liver Injury (DILI): | 0.187 | AMES Toxicity: | 0.662 |
Rat Oral Acute Toxicity: | 0.685 | Maximum Recommended Daily Dose: | 0.942 |
Skin Sensitization: | 0.951 | Carcinogencity: | 0.066 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.926 |
Respiratory Toxicity: | 0.663 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005673 | 0.550 | D07MGA | 0.326 | ||||
ENC005674 | 0.550 | D0H6QU | 0.310 | ||||
ENC002362 | 0.453 | D04AIT | 0.306 | ||||
ENC005677 | 0.436 | D0K8KX | 0.299 | ||||
ENC004765 | 0.434 | D0U3YB | 0.284 | ||||
ENC005672 | 0.432 | D0Y7PG | 0.274 | ||||
ENC005671 | 0.432 | D0R6BI | 0.273 | ||||
ENC004046 | 0.431 | D08QJS | 0.270 | ||||
ENC000337 | 0.400 | D02FCQ | 0.258 | ||||
ENC003862 | 0.368 | D0H2ZW | 0.253 |